ACTION: Anti-Cytokine Therapy for Hemodialysis Inflammation Trial
Jonathan Himmelfarb, MD
Completed Studies
Dialysis
Pinned
Principal Investigator
Jonathan Himmelfarb
Funding Agency
NIDDK HDNT Consortium
Status
Completed
Investigator
Jonathan Himmelfarb, MD
What is the ACTION Study?
The purpose of this study is to evaluate the safety and tolerability of the administration of the drug Anakinra in the suppression of inflammation in hemodialysis patients.
